Ani Pharmaceuticals reported $285.67M in Loan Capital for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Ani Pharmaceuticals ANIP:US USD 285.67M 213K
Aurora Cannabis Inc ACB:CN CAD 194.71M 91.36M
Canopy Growth Corp WEED:CN CAD 833.28M 290.12M
Depomed DEPO:US USD 66.4M 421K
Emergent Biosolutions EBS:US USD 448.5M 583.6M
Endo International Ordinary Shares ENDP:US USD 1.42M 8.05B
Heron Therapeutics HRTX:US USD 149.23M 52K
Hikma Pharmaceutical HIK:LN USD 1.14B 279M
Knight Therapeutics Inc GUD:CN CAD 57.45M 45.83M
Novartis NVS:US USD 21.78B 547M
Omeros OMER:US USD 346.49M 93.33M
Perrigo Ordinary Shares PRGO:US USD 4.07B 7.1M
Teva Pharmaceutical TEVA:IT USD 19.1B 606M
Teva Pharmaceutical Industries TEVA:US USD 19.1B 606M